Angiotensin-converting enzyme insertion/deletion polymorphism associated with acute respiratory distress syndrome among caucasians

Journal of International Medical Research

Volumn 38, Issue 2, 2010, Pages 415-422

  Hu, Z ^a   JIN, X ^a   Kang, Y ^a   Liu, C ^a   Zhou, Y ^a   Wu, X ^a   Liu, J ^a   Zhong, M ^a   Luo, C ^a   Deng, L ^a   Deng, Y ^a   Xie, X ^a   Zhang, Z ^a   Liao, X ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Acute respiratory distress syndrome; Angiotensin converting enzyme; Gene polymorphism; Meta analysis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT RESPIRATORY DISTRESS SYNDROME; CAUCASIAN; GENE DELETION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; INDEL MUTATION; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; REVIEW;

EID: 77953711249     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800204     Document Type: Review

References (21)

1. Deja M, Hommel M, Weber-Carstens S, et al: Evidence-based therapy of severe acute respiratory distress syndrome: an algorithm guided approach. J Int Med Res 2008; 36: 211-221.
2. Imai Y, Kuba K, Penninger JM: Angiotensin converting enzyme 2 in acute respiratory distress syndrome. Cell Mol Life Sci 2007; 64: 2006-2012.
3. Wu JS, Sheng L, Wang SH, et al: The impact of clinical risk factors in the conversion from acute lung injury to acute respiratory distress syndrome in severe multiple trauma patients. J Int Med Res 2008; 36: 579-586.
4. Kitamura N, Matsukawa Y, Takei M, et al: Antiproteinuric effect of angiotensin-converting enzyme inhibitors and an angiotensin II receptor blocker in patients with lupus nephritis. J Int Med Res 2009; 37: 892-898.
5. Petrovic I, Petrovic D, Vukovic N, et al: Ventricular and vascular remodelling effects of the angiotensin II receptor blocker telmisartan and/or the angiotensin-converting enzyme inhibitor ramipril in hypertensive patients. J Int Med Res 2005; 33(suppl 1): 39A-49A.
6. Rigat B, Hubert C, Alhenc-Gelas F, ef al: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
7. Okuno S, Utsugi T, Ohno T, et al: Angiotensin converting enzyme gene polymorphism as a potent risk factor for developing microalbuminuria in Japanese patients with type 2 diabetes mellitus: a 9-year follow-up study. J Int Med Res 2003; 31: 290-298.
8. Yamamoto T, Wang L, Shimakura K, et al Angiotensin H-induced pulmonary edema in a rabbit model. Jpn j Pharmacol 1997; 73: 33-40.
9. Quasney MW: Angiotensin-converting enzyme genetic variation and lung injury: are we genetically predisposed to develop acute respiratory distress syndrome? Crtt Care Med 2006; 34: 1261-1262.
10. del Castillo Rueda A, Guerrero Sanz JE, Escalante Cobo JL, et al. Serum and pulmonary angiotensin converting enzyme as a marker of acute lung injury in an experimental model of adult respiratory distress syndrome. An Med Interna 1999; 16: 229-235 [in Spanish].
11. Brugts JJ, Den Uil CA: ACE insertion/deletion polymorphism in sepsis and acute respiratory distress syndrome. Intensive Care Med 2008; 34: 1733; author reply 1732.
12. Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
13. Egger M, Davey Smith G, Schneider M, et al Bias in meta-analysis detected by a simple, graphical test. BMj 1997; 315: 629-634.
14. Marshall RP, Webb S, Bellingan GJ, et al Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am j Respir Crit Care Med 2002; 166: 646-650.
15. Chan KC, Tang NL, Hui DS, et al. Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: a case control study. BMC Infect Dis 2005; 5: 26.
16. Jerng JS, Yu CJ, Wang HC, et al. Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome. Crit Care Med 2006; 34: 1001-1006.
17. Adamzik M, Frey U, Sixt S, et al. ACE I/D but not ACT (-6)A/G polymorphism is a risk factor for mortality in ARDS. Eur Respir j 2007; 29: 482-488.
18. Villar J, Flores C, Perez-Mendez L, et al. Angiotensin-converting enzyme insertion/deletion polymorphism is not associated with susceptibility and outcome in sepsis and acute respiratory distress syndrome. Intensive Care Med 2008; 34: 488-495.
19. Ioannidis IP, Ntzani EE, Trikalinos TA, et al. Replication validity of genetic association studies. Nat Genet 2001; 29: 306-309.
20. Deng HW, Chen WM, Recker RR: Population admixture: detection by Hardy-Weinberg test and its quantitative effects on linkage disequilibrium methods for localizing genes underlying complex traits. Genetics 2001; 157: 885-897.
21. Marshall RP, Webb S, Hill MR, et al. Genetic polymorphisms associated with susceptibility and outcome in ARDS. Chest 2002; 121(3 suppl): 68S-69S.